By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genentech 

1 DNA Way

South San Francisco  California  94080-4990  U.S.A.
Phone: 650-225-1000 Fax: 650-225-6000


SEARCH JOBS
Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. Upon receiving U.S. Food and Drug Administration licensure in 2007, the Oceanside facility added 90,000 liters of capacity that are now approved for the production of Rituxan and Avastin bulk drug substance.

On the Southern California Coast, halfway between Los Angeles and San Diego, Oceanside is a beautiful beachfront community of roughly 200,000 people. As one of Oceanside’s largest employers, Genentech takes great pride in the impact we have on the community, but also in the impact the community has on our employees.

Please view our company video on YouTube:
http://www.youtube.com/genentech#p/u/1/GJH4X5gxxf0

Connect with us via Social Media:

Facebook: www.facebook.com/GenentechJobs

Twitter: www.twitter.com/GenentechJobs

LinkedIn: www.linkedin.com/company/genentech


Key Statistics


Email:
Ownership: Subsidiary

Web Site: Genentech
Employees: 10,000+
Symbol: RHHBY
 



Industry
Biotechnology

Segment
Biotherapeutics





Company News
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014 7:36:34 AM
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014 7:22:41 AM
Genentech (RHHBY) Submits Supplemental Biologics License Application To FDA For Lucentis Indication In Diabetic Retinopathy 8/8/2014 10:34:47 AM
GRAMMY® Award-Winning Singer Jennifer Hudson Lends Her Voice To Stand Up To Cancer And Genentech (RHHBY) In "Two Worlds. One Dream." Campaign In The Fight Against Cancer 7/30/2014 8:43:28 AM
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials 7/30/2014 8:02:41 AM
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer 7/22/2014 9:54:36 AM
That Model Genentech (RHHBY), Gilead Sciences, Inc. (GILD), And Amgen (AMGN) Were Built On—Does It Work Anymore? 7/16/2014 6:15:13 AM
Exelixis, Inc. (EXEL) And Genentech (RHHBY)'s Melanoma Combination Drug Meets Main Goal In Phase 3 Study 7/14/2014 6:33:22 AM
Genentech (RHHBY) To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals 7/2/2014 5:51:56 AM
Genentech (RHHBY) Bladder Cancer Med Anti-PDL1 (MPDL3280A) Nabs Breakthrough Status 6/2/2014 9:46:57 AM
12345678910...
//-->